marijuana stock news

Chuma Holdings, Inc. (CHUM)

 
Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Nov 30, 2014 Aug 31, 2014 May 31, 2014 Feb 28, 2014
Total Revenue 67   34   –   –  
Cost of Revenue (0) 0
Gross Profit 67   34   0   (0)
Operating Expenses
Research Development
Selling General and Administrative 1,017 497 133 28
Non Recurring 22
Others 0 0 0 0
Total Operating Expenses
Operating Income or Loss (972) (464) (133) (28)
Income from Continuing Operations
Total Other Income/Expenses Net 518 12
Earnings Before Interest And Taxes (454) (452) (133) (28)
Interest Expense 7 8 8 7
Income Before Tax (461) (459) (140) (36)
Income Tax Expense
Minority Interest
Net Income From Continuing Ops (461) (459) (140) (36)
Non-recurring Events
Discontinued Operations (2)
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income (461) (459) (143) (36)
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares (461) (459) (143) (36

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

IMLFF Receives Exemption Status from Health Canada

InMed Receives Exemption Status from Health Canada   VANCOUVER, British Columbia, March…

INSYS Therapeutics, Inc. (INSY) Clinical Data from Long-Term Safety-Study To Be Presented at American Epilepsy Society Meeting

Clinical Data from Long-Term Safety-Study of Company’s Pharmaceutical CBD in Refractory Pediatric…

Tilray Brands, Inc. (TLRY) Launches Redecan Cannabis Brand in Australia

Tilray Medical Launches Redecan Cannabis Brand in Australia Tilray Medical, a division…

InMed Pharmaceuticals Inc. (IMLFF) Receives CTA Approval for Second Phase 1 Clinical Trial with INM-755

InMed Receives CTA Approval for Second Phase 1 Clinical Trial with INM-755…